Patients with melanoma of unknown primary show better outcome under immune checkpoint inhibitor therapy than patients with known primary: preliminary results.

Oncoimmunology · 2019 · PMC6844308 · PMID 31741779

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a statistical trendno p-value reported

Due to the small sample size, we likely observed only a statistical trend for better response to ICPI treatment in patients with MUP as compared to patients with MKP.

also in 2,492 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.